Tag: https://www.bio.org/events/bio-international-convention
U.S. Senator Martin Heinrich (D-N.M.) questioned FDA Commissioner Dr. Robert Califf on the impact of a federal court decision on … source
BIO JOINS AMICUS BRIEF CHALLENGING COURT’S EFFORTS TO UNDERMINE FDA’S AUTHORITY TO BRING TREATMENTS … source
CSBA heads to Capitol Hill The Council of State Bioscience Associations (CSBA), a coalition of state-based bioscience trade … source
The House Energy & Commerce Health Subcommittee held a hearing on President Biden’s 2024 budget proposal. Subcommittee Chair Rep. Brett Guthrie (R-KY) asked Health and Human Services Secretary Xavier Becerra whether the plight of small businesses and the impact on innovation was considered when the administration included expanded drug price controls in the budget proposal. […]
BIO at TRIPS hearing: Actions matter to investors The threat of expanding IP waivers by the World Trade Organization (WTO) dampens investment in research, BIO’s Chief Policy Officer John Murphy testified yesterday before the U.S. International Trade Commission (USITC). What’s happening at USITC? The U.S. Trade Representative is weighing whether to support extending the WTO’s […]